{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:55:23Z","timestamp":1787003723943,"version":"build-2736575974"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T00:00:00Z","timestamp":1727395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T00:00:00Z","timestamp":1727395200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32271320"],"award-info":[{"award-number":["32271320"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Creative Research Group of Zhongshan City","award":["CXTD2022011"],"award-info":[{"award-number":["CXTD2022011"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-73625-z","type":"journal-article","created":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T13:02:29Z","timestamp":1727442149000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Identification of immune patterns in idiopathic pulmonary fibrosis patients driven by PLA2G7-positive macrophages using an integrated machine learning survival framework"],"prefix":"10.1038","volume":"14","author":[{"given":"Tianxi","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyuan","family":"Ning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqing","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangsen","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingshan Bill","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,27]]},"reference":[{"key":"73625_CR1","doi-asserted-by":"publisher","first-page":"17074","DOI":"10.1038\/nrdp.2017.74","volume":"3","author":"FJ Martinez","year":"2017","unstructured":"Martinez, F. J. et al. Idiopathic pulmonary fibrosis. Nat. Rev. Dis. Primers. 3, 17074 (2017).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"73625_CR2","doi-asserted-by":"publisher","first-page":"00597","DOI":"10.1183\/23120541.00597-2021","volume":"8","author":"O Hilberg","year":"2022","unstructured":"Hilberg, O. et al. Epidemiology of interstitial lung diseases and their progressive-fibrosing behaviour in six European countries. ERJ Open. Res.8, 00597\u201302021 (2022).","journal-title":"ERJ Open. Res."},{"key":"73625_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1126\/scitranslmed.3005964","volume":"5","author":"JD Herazo-Maya","year":"2013","unstructured":"Herazo-Maya, J. D. et al. Peripheral blood mononuclear cell gene expression profiles predict poor outcome in idiopathic pulmonary fibrosis. Sci. Transl. Med.5, 1 (2013).","journal-title":"Sci. Transl. Med."},{"key":"73625_CR4","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s40248-019-0197-0","volume":"14","author":"C Quinn","year":"2019","unstructured":"Quinn, C., Wisse, A. & Manns, S. T. Clinical course and management of idiopathic pulmonary fibrosis. Multidiscip Respir Med.14, 35 (2019).","journal-title":"Multidiscip Respir Med."},{"key":"73625_CR5","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1177\/1753465816686743","volume":"11","author":"MJG Van Manen","year":"2017","unstructured":"Van Manen, M. J. G., Geelhoed, J. J., Miranda., Tak, N. C. & Wijsenbeek, M. S. Optimizing quality of life in patients with idiopathic pulmonary fibrosis. Ther. Adv. Respir Dis.11, 157\u2013169 (2017).","journal-title":"Ther. Adv. Respir Dis."},{"key":"73625_CR6","doi-asserted-by":"publisher","first-page":"2300240","DOI":"10.1183\/13993003.00240-2023","volume":"61","author":"M Lehmann","year":"2023","unstructured":"Lehmann, M. & Kolb, M. Another piece in the pirfenidone puzzle. Eur. Respir J.61, 2300240 (2023).","journal-title":"Eur. Respir J."},{"key":"73625_CR7","doi-asserted-by":"publisher","first-page":"1702106","DOI":"10.1183\/13993003.02106-2017","volume":"52","author":"I Noth","year":"2018","unstructured":"Noth, I., Oelberg, D., Kaul, M., Conoscenti, C. S. & Raghu, G. Safety and tolerability of nintedanib in patients with idiopathic pulmonary fibrosis in the USA. Eur. Respir J.52, 1702106 (2018).","journal-title":"Eur. Respir J."},{"key":"73625_CR8","doi-asserted-by":"publisher","first-page":"104766","DOI":"10.1016\/j.ebiom.2023.104766","volume":"95","author":"T Karampitsakos","year":"2023","unstructured":"Karampitsakos, T., Juan-Guardela, B. M. & Tzouvelekis, A. Herazo-Maya, J. D. Precision medicine advances in idiopathic pulmonary fibrosis. eBioMedicine. 95, 104766 (2023).","journal-title":"eBioMedicine"},{"key":"73625_CR9","doi-asserted-by":"publisher","first-page":"2200777","DOI":"10.1183\/13993003.00777-2022","volume":"61","author":"F Cui","year":"2023","unstructured":"Cui, F. et al. Air pollutants, genetic susceptibility and risk of incident idiopathic pulmonary fibrosis. Eur. Respir J.61, 2200777 (2023).","journal-title":"Eur. Respir J."},{"key":"73625_CR10","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1164\/rccm.202207-1331OC","volume":"207","author":"AL Peljto","year":"2023","unstructured":"Peljto, A. L. et al. Idiopathic pulmonary fibrosis is associated with common genetic variants and limited rare variants. Am. J. Respir Crit. Care Med.207, 1194\u20131202 (2023).","journal-title":"Am. J. Respir Crit. Care Med."},{"key":"73625_CR11","doi-asserted-by":"publisher","unstructured":"Guo, S. et al. Integrative analysis reveals the recurrent genetic etiologies in idiopathic pulmonary fibrosis. QJM: Int. J. Med.\u00a0hcad206.\u00a0https:\/\/doi.org\/10.1093\/qjmed\/hcad206 (2023).","DOI":"10.1093\/qjmed\/hcad206"},{"key":"73625_CR12","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1146\/annurev-med-041317-102715","volume":"70","author":"JA Kropski","year":"2019","unstructured":"Kropski, J. A. & Blackwell, T. S. Progress in understanding and treating idiopathic pulmonary fibrosis. Annu. Rev. Med.70, 211\u2013224 (2019).","journal-title":"Annu. Rev. Med."},{"key":"73625_CR13","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.rmed.2018.12.015","volume":"147","author":"P Heukels","year":"2019","unstructured":"Heukels, P., Moor, C. C., Von Der Th\u00fcsen, J. H., Wijsenbeek, M. S. & Kool, M. Inflammation and immunity in IPF pathogenesis and treatment. Respir. Med.147, 79\u201391 (2019).","journal-title":"Respir. Med."},{"key":"73625_CR14","doi-asserted-by":"publisher","first-page":"676569","DOI":"10.3389\/fmolb.2021.676569","volume":"8","author":"G Ishikawa","year":"2021","unstructured":"Ishikawa, G., Liu, A. & Herzog, E. L. Evolving perspectives on Innate Immune mechanisms of IPF. Front. Mol. Biosci.8, 676569 (2021).","journal-title":"Front. Mol. Biosci."},{"key":"73625_CR15","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1038\/s41551-018-0315-x","volume":"2","author":"Towards trustable machine learning","year":"2018","unstructured":"Towards trustable machine learning. Nat. Biomed. Eng.2, 709\u2013710 (2018).","journal-title":"Nat. Biomed. Eng."},{"key":"73625_CR16","doi-asserted-by":"publisher","first-page":"e13409","DOI":"10.1111\/cpr.13409","volume":"56","author":"N Zhang","year":"2023","unstructured":"Zhang, N. et al. An artificial intelligence network-guided signature for predicting outcome and immunotherapy response in lung adenocarcinoma patients based on 26 machine learning algorithms. Cell Prolif.56, e13409 (2023).","journal-title":"Cell Prolif."},{"key":"73625_CR17","doi-asserted-by":"publisher","first-page":"7019","DOI":"10.1038\/s41598-023-34291-9","volume":"13","author":"J Ning","year":"2023","unstructured":"Ning, J. et al. Use of machine learning-based integration to develop an immune-related signature for improving prognosis in patients with gastric cancer. Sci. Rep.13, 7019 (2023).","journal-title":"Sci. Rep."},{"key":"73625_CR18","doi-asserted-by":"publisher","first-page":"e80150","DOI":"10.7554\/eLife.80150","volume":"11","author":"L Wang","year":"2022","unstructured":"Wang, L. et al. Comprehensive machine-learning survival framework develops a consensus model in large-scale multicenter cohorts for pancreatic cancer. eLife. 11, e80150 (2022).","journal-title":"eLife"},{"key":"73625_CR19","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s10020-023-00634-5","volume":"29","author":"J Ning","year":"2023","unstructured":"Ning, J. et al. Use of machine learning-based integration to develop a monocyte differentiation-related signature for improving prognosis in patients with sepsis. Mol. Med.29, 37 (2023).","journal-title":"Mol. Med."},{"key":"73625_CR20","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1164\/rccm.201712-2551OC","volume":"199","author":"A Prasse","year":"2019","unstructured":"Prasse, A. et al. BAL Cell Gene expression is indicative of outcome and airway basal cell involvement in idiopathic pulmonary fibrosis. Am. J. Respir Crit. Care Med.199, 622\u2013630 (2019).","journal-title":"Am. J. Respir Crit. Care Med."},{"key":"73625_CR21","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/s12931-018-0857-1","volume":"19","author":"MJ Cecchini","year":"2018","unstructured":"Cecchini, M. J., Hosein, K., Howlett, C. J., Joseph, M. & Mura, M. Comprehensive gene expression profiling identifies distinct and overlapping transcriptional profiles in non-specific interstitial pneumonia and idiopathic pulmonary fibrosis. Respir Res.19, 153 (2018).","journal-title":"Respir Res."},{"key":"73625_CR22","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1164\/rccm.200810-1596OC","volume":"180","author":"K Konishi","year":"2009","unstructured":"Konishi, K. et al. Gene expression profiles of Acute exacerbations of Idiopathic Pulmonary Fibrosis. Am. J. Respir Crit. Care Med.180, 167\u2013175 (2009).","journal-title":"Am. J. Respir Crit. Care Med."},{"key":"73625_CR23","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie, M. E. et al. Limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res.43, e47\u2013e47 (2015).","journal-title":"Nucleic Acids Res."},{"key":"73625_CR24","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/nature08460","volume":"462","author":"DA Barbie","year":"2009","unstructured":"Barbie, D. A. et al. Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1. Nature. 462, 108\u2013112 (2009).","journal-title":"Nature"},{"key":"73625_CR25","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/j.ccell.2021.04.014","volume":"39","author":"A Bagaev","year":"2021","unstructured":"Bagaev, A. et al. Conserved pan-cancer microenvironment subtypes predict response to immunotherapy. Cancer Cell.39, 845\u2013865e7 (2021).","journal-title":"Cancer Cell."},{"key":"73625_CR26","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1093\/bioinformatics\/btq170","volume":"26","author":"MD Wilkerson","year":"2010","unstructured":"Wilkerson, M. D. & Hayes, D. N. ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking. Bioinformatics. 26, 1572\u20131573 (2010).","journal-title":"Bioinformatics"},{"key":"73625_CR27","first-page":"100141","volume":"2","author":"T Wu","year":"2021","unstructured":"Wu, T. et al. clusterProfiler 4.0: a universal enrichment tool for interpreting omics data. Innov.2, 100141 (2021).","journal-title":"Innov."},{"key":"73625_CR28","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/75556","volume":"25","author":"M Ashburner","year":"2000","unstructured":"Ashburner, M. et al. Gene Ontology: tool for the unification of biology. Nat. Genet.25, 25\u201329 (2000).","journal-title":"Nat. Genet."},{"key":"73625_CR29","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"MKEGG Kanehisa","year":"2000","unstructured":"Kanehisa, M. K. E. G. G. Kyoto Encyclopedia of genes and genomes. Nucleic Acids Res.28, 27\u201330 (2000).","journal-title":"Nucleic Acids Res."},{"key":"73625_CR30","doi-asserted-by":"publisher","first-page":"1230266","DOI":"10.3389\/fimmu.2023.1230266","volume":"14","author":"J Lv","year":"2023","unstructured":"Lv, J. et al. Dynamic atlas of immune cells reveals multiple functional features of macrophages associated with progression of pulmonary fibrosis. Front. Immunol.14, 1230266 (2023).","journal-title":"Front. Immunol."},{"key":"73625_CR31","doi-asserted-by":"publisher","unstructured":"Hao, Y. et al. Dictionary learning for integrative, multimodal and scalable single-cell analysis. Nat. Biotechnol.\u00a0https:\/\/doi.org\/10.1038\/s41587-023-01767-y (2023).","DOI":"10.1038\/s41587-023-01767-y"},{"key":"73625_CR32","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1038\/s41592-019-0619-0","volume":"16","author":"I Korsunsky","year":"2019","unstructured":"Korsunsky, I. et al. Fast, sensitive and accurate integration of single-cell data with Harmony. Nat. Methods. 16, 1289\u20131296 (2019).","journal-title":"Nat. Methods"},{"key":"73625_CR33","doi-asserted-by":"publisher","first-page":"5692","DOI":"10.1038\/s41467-021-25960-2","volume":"12","author":"JW Squair","year":"2021","unstructured":"Squair, J. W. et al. Confronting false discoveries in single-cell differential expression. Nat. Commun.12, 5692 (2021).","journal-title":"Nat. Commun."},{"key":"73625_CR34","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1016\/S0140-6736(17)30866-8","volume":"389","author":"L Richeldi","year":"2017","unstructured":"Richeldi, L., Collard, H. R. & Jones, M. G. Idiopathic pulmonary fibrosis. Lancet. 389, 1941\u20131952 (2017).","journal-title":"Lancet"},{"key":"73625_CR35","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/j.immuni.2016.01.001","volume":"44","author":"JL Larson-Casey","year":"2016","unstructured":"Larson-Casey, J. L., Deshane, J. S., Ryan, A. J., Thannickal, V. J. & Carter, A. B. Macrophage Akt1 kinase-mediated Mitophagy modulates apoptosis resistance and pulmonary fibrosis. Immunity. 44, 582\u2013596 (2016).","journal-title":"Immunity"},{"key":"73625_CR36","doi-asserted-by":"publisher","first-page":"2003721","DOI":"10.1183\/13993003.03721-2020","volume":"59","author":"J Wang","year":"2022","unstructured":"Wang, J. et al. Nestin promotes pulmonary fibrosis via facilitating recycling of TGF-\u03b2 receptor I. Eur. Respir J.59, 2003721 (2022).","journal-title":"Eur. Respir J."},{"key":"73625_CR37","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/0959-440X(95)80064-6","volume":"5","author":"A Szabo","year":"1995","unstructured":"Szabo, A., Stolz, L. & Granzow, R. Surface plasmon resonance and its use in biomolecular interaction analysis (BIA). Curr. Opin. Struct. Biol.5, 699\u2013705 (1995).","journal-title":"Curr. Opin. Struct. Biol."},{"key":"73625_CR38","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.celrep.2016.12.019","volume":"18","author":"P Charoentong","year":"2017","unstructured":"Charoentong, P. et al. Pan-cancer immunogenomic analyses reveal genotype-immunophenotype relationships and predictors of response to checkpoint blockade. Cell. Rep.18, 248\u2013262 (2017).","journal-title":"Cell. Rep."},{"key":"73625_CR39","doi-asserted-by":"publisher","unstructured":"Fastr\u00e8s, A. et al. Osteopontin and fibronectin in lung tissue, serum, and bronchoalveolar lavage fluid of dogs with idiopathic pulmonary fibrosis and control dogs. Veterinary Intern. Med. JVIM. 16870.\u00a0https:\/\/doi.org\/10.1111\/jvim.16870 (2023).","DOI":"10.1111\/jvim.16870"},{"key":"73625_CR40","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1038\/s41591-023-02327-2","volume":"29","author":"L Sikkema","year":"2023","unstructured":"Sikkema, L. et al. An integrated cell atlas of the lung in health and disease. Nat. Med.29, 1563\u20131577 (2023).","journal-title":"Nat. Med."},{"key":"73625_CR41","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1136\/thoraxjnl-2021-216882","volume":"77","author":"A Kumar","year":"2022","unstructured":"Kumar, A. et al. Inhibition of PDIA3 in club cells attenuates osteopontin production and lung fibrosis. Thorax. 77, 669\u2013678 (2022).","journal-title":"Thorax"},{"key":"73625_CR42","doi-asserted-by":"publisher","first-page":"2101612","DOI":"10.1183\/13993003.01612-2021","volume":"59","author":"FA Khan","year":"2022","unstructured":"Khan, F. A., Stewart, I., Saini, G., Robinson, K. A. & Jenkins, R. G. A systematic review of blood biomarkers with individual participant data meta-analysis of matrix metalloproteinase-7 in idiopathic pulmonary fibrosis. Eur. Respir J.59, 2101612 (2022).","journal-title":"Eur. Respir J."},{"key":"73625_CR43","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1016\/j.chest.2020.04.066","volume":"158","author":"A Adegunsoye","year":"2020","unstructured":"Adegunsoye, A. et al. Circulating plasma biomarkers of survival in antifibrotic-treated patients with idiopathic pulmonary fibrosis. Chest. 158, 1526\u20131534 (2020).","journal-title":"Chest"},{"key":"73625_CR44","doi-asserted-by":"publisher","first-page":"1802441","DOI":"10.1183\/13993003.02441-2018","volume":"54","author":"C Morse","year":"2019","unstructured":"Morse, C. et al. Proliferating SPP1\/MERTK-expressing macrophages in idiopathic pulmonary fibrosis. Eur. Respir J.54, 1802441 (2019).","journal-title":"Eur. Respir J."},{"key":"73625_CR45","doi-asserted-by":"publisher","first-page":"2519","DOI":"10.1056\/NEJMoa1611593","volume":"375","author":"SE Nissen","year":"2016","unstructured":"Nissen, S. E. et al. Cardiovascular Safety of Celecoxib, Naproxen, or Ibuprofen for Arthritis. N Engl. J. Med.375, 2519\u20132529 (2016).","journal-title":"N Engl. J. Med."},{"key":"73625_CR46","doi-asserted-by":"publisher","first-page":"1602419","DOI":"10.1183\/13993003.02419-2016","volume":"50","author":"B Duchemann","year":"2017","unstructured":"Duchemann, B. et al. Prevalence and incidence of interstitial lung diseases in a multi-ethnic county of Greater Paris. Eur. Respir J.50, 1602419 (2017).","journal-title":"Eur. Respir J."},{"key":"73625_CR47","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1146\/annurev.iy.12.040194.001041","volume":"12","author":"PA Baeuerle","year":"1994","unstructured":"Baeuerle, P. A. & Henkel, T. Function and activation of NF-kappaB in the Immune System. Annu. Rev. Immunol.12, 141\u2013179 (1994).","journal-title":"Annu. Rev. Immunol."},{"key":"73625_CR48","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1038\/ni.3691","volume":"18","author":"AV Villarino","year":"2017","unstructured":"Villarino, A. V., Kanno, Y. & O\u2019Shea, J. J. Mechanisms and consequences of Jak\u2013STAT signaling in the immune system. Nat. Immunol.18, 374\u2013384 (2017).","journal-title":"Nat. Immunol."},{"key":"73625_CR49","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1136\/thoraxjnl-2021-217315","volume":"77","author":"W Whalen","year":"2022","unstructured":"Whalen, W. et al. Association of circulating cell-free double-stranded DNA and metabolic derangements in idiopathic pulmonary fibrosis. Thorax. 77, 186\u2013190 (2022).","journal-title":"Thorax"},{"key":"73625_CR50","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1007\/s00109-023-02336-1","volume":"101","author":"R Chen","year":"2023","unstructured":"Chen, R. & Dai, J. Lipid metabolism in idiopathic pulmonary fibrosis: from pathogenesis to therapy. J. Mol. Med.101, 905\u2013915 (2023).","journal-title":"J. Mol. Med."},{"key":"73625_CR51","doi-asserted-by":"publisher","first-page":"5728","DOI":"10.1038\/s41467-023-41462-9","volume":"14","author":"M Oh","year":"2023","unstructured":"Oh, M. et al. The lipoprotein-associated phospholipase A2 inhibitor Darapladib sensitises cancer cells to ferroptosis by remodelling lipid metabolism. Nat. Commun.14, 5728 (2023).","journal-title":"Nat. Commun."},{"key":"73625_CR52","doi-asserted-by":"publisher","first-page":"106286","DOI":"10.1016\/j.phrs.2022.106286","volume":"182","author":"J Wang","year":"2022","unstructured":"Wang, J. et al. Integrated analysis of single-cell and bulk RNA sequencing reveals pro-fibrotic PLA2G7high macrophages in pulmonary fibrosis. Pharmacol. Res.182, 106286 (2022).","journal-title":"Pharmacol. Res."},{"key":"73625_CR53","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/s41420-022-00831-x","volume":"8","author":"J Wang","year":"2022","unstructured":"Wang, J. et al. Characterizing cellular heterogeneity in fibrotic hypersensitivity pneumonitis by single-cell transcriptional analysis. Cell. Death Discov. 8, 38 (2022).","journal-title":"Cell. Death Discov"},{"key":"73625_CR54","doi-asserted-by":"publisher","first-page":"119203","DOI":"10.1016\/j.lfs.2021.119203","volume":"272","author":"S Tang","year":"2021","unstructured":"Tang, S. et al. Celecoxib ameliorates liver cirrhosis via reducing inflammation and oxidative stress along spleen-liver axis in rats. Life Sci.272, 119203 (2021).","journal-title":"Life Sci."},{"key":"73625_CR55","doi-asserted-by":"crossref","unstructured":"Ji, Y. et al. Celecoxib attenuates hindlimb unloading-induced muscle atrophy via suppressing inflammation, oxidative stress and ER stress by inhibiting STAT3. Inflammopharmacol32, 1633\u20131646 (2024).","DOI":"10.1007\/s10787-024-01454-7"},{"key":"73625_CR56","doi-asserted-by":"crossref","unstructured":"Fidahic, M., Jelicic Kadic, A., Radic, M. & Puljak, L. Celecoxib for rheumatoid arthritis. Cochrane Database Syst. Rev.\u00a0(2017).","DOI":"10.1002\/14651858.CD012095"},{"key":"73625_CR57","doi-asserted-by":"publisher","first-page":"380","DOI":"10.3390\/ph14040380","volume":"14","author":"H Alsaegh","year":"2021","unstructured":"Alsaegh, H., Eweis, H., Kamel, F. & Alrafiah, A. Celecoxib decrease seizures susceptibility in a rat model of inflammation by inhibiting HMGB1 translocation. Pharmaceuticals. 14, 380 (2021).","journal-title":"Pharmaceuticals"},{"key":"73625_CR58","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1016\/j.jacc.2018.02.036","volume":"71","author":"GW Reed","year":"2018","unstructured":"Reed, G. W. et al. Effect of aspirin coadministration on the safety of Celecoxib, Naproxen, or Ibuprofen. J. Am. Coll. Cardiol.71, 1741\u20131751 (2018).","journal-title":"J. Am. Coll. Cardiol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-73625-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-73625-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-73625-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T03:44:25Z","timestamp":1727667865000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-73625-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,27]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["73625"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-73625-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,27]]},"assertion":[{"value":"13 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All methods were carried out in accordance with relevant guidelines and regulations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have agreed to publish this manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"22369"}}